Stockreport

Arcutis Biotherapeutics Q4 Earnings Call Highlights [Yahoo! Finance]

Arcutis Biotherapeutics, Inc. - Common stock  (ARQT) 
PDF Arcutis Biotherapeutics (NASDAQ:ARQT) reported fourth-quarter and full-year fiscal 2025 results highlighted by sharp growth in ZORYVE net product revenue, additional FD [Read more]